The race is on to find novel solutions for managing pain. In a country plagued by the opioid crisis, the race is on to find novel solutions for managing pain. One in five Americans experience some ...

Explore the latest guidelines for treating neuropathic pain, based on a comprehensive study by the International Association for the Study of Pain’s NeuPSIG. This research evaluates both drug and ...

Suffering from chronic pain can be both a debilitating and lonely experience. Often unaccompanied by outside markers of distress, an actual diagnosis — whether it be lingering pain from an old injury, ...

The opioid crisis remains a significant public health challenge in the United States. In 2022, over 2.5 million American adults had an opioid use disorder, and opioids accounted for nearly 76% of ...

British researchers found that beta-blockers were associated with a reduced risk for primary care consultations for knee osteoarthritis and knee and hip pain. A review of the findings was the top ...

Perineuronal nets, rigid structures that hold certain neurons in place, affect a surprising amount of brain activity, including some associated with chronic pain. Neuroscientists, being interested in ...

Pain is an important physiological response in living organisms. While physical pain is an outcome of tissue damage, pain can manifest as diverse unpleasant sensory and emotional experiences.

Researchers have identified a unique population of astrocytes in the dorsal horn of the spinal cord of mice that produces pain hypersensitivity when activated by neurons carrying signals down from the ...

The School of Dentistry at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) earned the first National Institutes of Health grant under its new Center for Pain ...

On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe pain. The prescription pills, sold under the brand name Journavx and made by ...